KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Invested Capital (2016 - 2025)

Historic Invested Capital for Gsk (GSK) over the last 17 years, with Q1 2025 value amounting to $1.7 billion.

  • Gsk's Invested Capital changed N/A to $1.7 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.7 billion, marking a year-over-year change of. This contributed to the annual value of $63.7 billion for FY2024, which is 126.6% up from last year.
  • Gsk's Invested Capital amounted to $1.7 billion in Q1 2025.
  • In the past 5 years, Gsk's Invested Capital ranged from a high of $64.0 billion in Q4 2024 and a low of $1.7 billion during Q1 2025
  • For the 5-year period, Gsk's Invested Capital averaged around $32.4 billion, with its median value being $32.6 billion (2022).
  • Per our database at Business Quant, Gsk's Invested Capital crashed by 3068.83% in 2022 and then surged by 9252.17% in 2023.
  • Over the past 5 years, Gsk's Invested Capital (Quarter) stood at $47.0 billion in 2021, then tumbled by 30.69% to $32.6 billion in 2022, then soared by 92.52% to $62.8 billion in 2023, then rose by 1.9% to $64.0 billion in 2024, then crashed by 97.34% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q1 2025, $64.0 billion for Q4 2024, and $62.8 billion during Q4 2023.